President of Anika Therapeutics Picks Up 51% More Stock
Bullish On Anika Therapeutics's Pullback As Integrity Scales
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary
Anika Therapeutics Q1 Earnings Call Highlights
Anika Therapeutics Inc (NASDAQ:ANIK) Soars on Q1 Earnings and Revenue Beat
Anika Therapeutics, Inc. (ANIK) Q1 2026 Earnings Call Transcript
Anika Reports First Quarter 2026 Financial Results
Anika Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Anika Therapeutics Affirms FY2026 Sales Guidance of $114.000M-$122.500M vs $117.220M Est
Anika Therapeutics Q1 Adj. EPS $0.27 Beats $(0.16) Estimate, Sales $29.612M Beat $28.142M Estimate
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Top 2 Health Care Stocks That May Crash This Quarter
Anika Therapeutics, Inc. (ANIK) Presents at 2026 CG Musculoskeletal Conference - Slideshow
Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary
Anika Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation
Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ...
Anika Therapeutics Q4 Earnings Call Highlights
ANIKA THERAPEUTICS INC (NASDAQ:ANIK) Delivers Decisive Q4 2025 Earnings Beat, Sparking Share Rally
Anika Therapeutics, Inc. (ANIK) Q4 2025 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.